Emerging Growth Companies and Venture Capital

• Semperis, a leading cybersecurity company, in connection with financing and general corporate matters.
• Guggenheim Investments, in connection with various equity investment matters.
• Galway Sustainable Capital, in connection with its $250 million financing.
• Orchestra BioMed, Inc., a biomedical innovation company, in connection with various corporate matters and transactions, including its $72 million Series B/B1 financings and its $110 million Series D financing
• Annexus Health, Inc., in connection with its $33 million Series B financing.
• Clearview AI, a leading facial recognition company, in connection with its $30 million Series B financing.
• CurbWaste, in connection with its $10 million Series A financing.​
• Deerfield Management Company, in connection with various investments and joint ventures.
• RSE Ventures, the venture arm of Miami Dolphins owner and The Related Companies Chairman Stephen Ross, in connection with various transactions, including:
  • its preferred equity investment in the Momofuku Restaurant Group;
  • its preferred equity investment in the Fuku fast-casual restaurant chain;
  • its preferred equity investment in Milk Bar; and
  • its preferred equity investment in &pizza.
• Digitalis Ventures, in connection with general corporate matters and various debt and equity investments.
• Ascent Biomedical Ventures, in connection with various debt and minority equity investments.
• Orchestra Medical Ventures, in connection with various debt and minority equity investments.
• Nyca Partners, in connection with various equity investments.
• Subversive Capital, in connection with various debt and equity investments.
• Represented both companies and venture capital investors in various preferred stock financing rounds. 
• Represented various foreign companies in connection with U.S. investments.
• Represented various early stage startup companies in connection with general corporate matters and financing.

Mergers & Acquisitions and Joint Ventures

• Orchestra BioMed, Inc., a biomedical innovation company, in connection with various corporate matters and transactions, including its business combination agreement to merge with a special purpose acquisition company (SPAC)
• Represented Merck in a strategic collaboration with Amathus Therapeutics to develop novel small molecule therapeutic candidates for neurodegenerative diseases.
• Represented Elanco US Inc., a subsidiary of Eli Lilly and Company, in its acquisition of Boehringer Ingelheim Vetmedica’s U.S. feline, canine and rabies vaccines portfolio and Fort Dodge manufacturing and R&D site for approximately $885 million.
• Represented Merck in connection with its acquisition of Afferent Pharmaceuticals. 
• Formation counsel to Technicolor and Sony Corporation's joint patent licensing program for digital television (DTV) and computer display monitor (CDM).

• Navigating Control Mechanisms in Startups, JD Supra; Lexology (April 2024)
• Delaware Chancery Court Invalidates Moelis Shareholder Agreement, JD Supra; Lexology (March 2024)
• New NVCA Model Legal Documents - Now With Recent Market Data, JD Supra, Lexology (September 2022)
• 2021: Venture Capital Year in Review, Lexology (March 2022)
• Panelist, "Alumni Talks Series" for The Garnet Society, the Union College Student-Alumni Association (October 2020).
• Broker Registration Requirements: The SEC Proposes a Limited Conditional Exemption for Finders, Lexology (October 2020).
• Moderator, Union College "Money on the Mind" Financial Workshop Series (September 2020).
• PLX Likely Stands On Its Own, But Has Room To Grow, Lexology (November 2019).
• Smarter, Faster, Stronger: A New Suite of VC Model Documents, Law360; Lexology (May 2018).
• NYC: Municipal Benefactor to Life Sciences and Technology Venture Capital, Lexology (November 2017).
• Panelist, "Making an Impact: Entrepreneurship & Creative Problem-Solving" (May 2017).
• Contributor, Lexis Nexis Practice Advisor - Private Equity Content (March 2017 to Present).
• Guest Lecturer, Cornell Tech Master of Laws (LLM) program on international intellectual property transactions (March 2017).
• Resigning from a Board of Directors: Considerations for VC Fund Designees, Lexology (March 2017).
• Venture Debt: An Attractive Tool for Startup Companies, Law360 (February 2017).
• The Calculus of Going Hostile: Recent Lessons from the Field, Law360 (April 2015).

• Paul Hastings Securities and Capital Markets Associate Committee (2024 – Present)
• Paul Hastings Pro Bono Committee Co-Chair, New York Office (2021 - Present); Pro Bono Coordinator, New York Office (2020-2021)
• New York City Community Board 5 (Manhattan), Member; Public Safety and Quality of Life Committee; Transportation and the Environment Committee (2019 - 2021)
• Union College Campaign Steering Committee (2020-Present), GOLD Program Co-Chair (2020-2023)
• Alumni Council of Union College, Elected Member (2019-Present)
• Paul Hastings New York Recruiting Committee Member (2019 - Present)
• Paul Hastings Talent Development Committee Member (2016 - 2019)
• New York County Lawyers Association, Corporate Section Member (2015 - Present)
• Pro Bono Attorney Participant for Sanctuary for Families, Election Protection and Volunteer Lawyers for the Arts (2015 - Present)
• Union College Alumni Club of New York City, Board Member (2015 - Present)